References

Berman, D. M., Willman, M. A., Han, D., Kleiner, G., Kenyon, N. M., Cabrera, O., ... & Ricordi, C. (2016). The omentum as a site for islet transplantation. Current Opinion in Organ Transplantation, 21(5), 461–468.

Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999). Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes, 48(2), 241–253.

Opara, E. C., & Kendall, W. F. (2002). Immunoisolation techniques for islet cell transplantation. Expert Opinion on Biological Therapy, 2(5), 503–511.

Dev, P., Chaurasia, R. N., & Pathak, A. (2026). Soluble form of receptor for advanced glycation end product receptors as novel therapeutic intervention to arrest amyloid-associated pathogenesis. In Diabetes and Neurodegeneration (pp. 535-542). Academic Press.

Vaithilingam, V., & Tuch, B. E. (2011). Islet transplantation and encapsulation: An update on recent developments. The Review of Diabetic Studies, 8(1), 51–67.

Westermark, P., Andersson, A., & Westermark, G. T. (2011). Islet amyloid polypeptide, islet amyloid, and diabetes. Physiological Reviews, 91(3), 795–826.

Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010). Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response. Annual Review of Medicine, 60, 419–429.